MPR Weekly Dose Podcast #189

Biogen discontinues Alzheimer disease treatment; the American Academy of Dermatology issues new acne vulgaris management guidelines; update for EUA-labeled Paxlovid availability; narcolepsy/ADHD treatment recalled; FDA warns against copycat eye drop products.